Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Cell Signaling Technology patents

Patents where

Current Assignee

Name

Cell Signaling Technology

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11428696 Mass spectrometry analysis of mutant polypeptides in biological samples	Patent 11428696 was granted and assigned to Cell Signaling Technology on August, 2022 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	11428696	August 30, 2022
‌ US Patent 11505833 Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer	Patent 11505833 was granted and assigned to Cell Signaling Technology on November, 2022 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	11505833	November 22, 2022
‌ US Patent 11377486 Motif-specific and context-independent antibodies that specifically bind to a sumoylated lysine-containing residue	Patent 11377486 was granted and assigned to Cell Signaling Technology on July, 2022 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	11377486	July 5, 2022
‌ US Patent 9523130 Methods of treating non-small cell lung carcinoma (NSCLC)	Patent 9523130 was granted and assigned to Cell Signaling Technology on December, 2016 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9523130	December 20, 2016
‌ US Patent 8486645 Gene defects and mutant ALK kinase in human solid tumors	Patent 8486645 was granted and assigned to Cell Signaling Technology on July, 2013 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	8486645	July 16, 2013
‌ US Patent 10955416 Compositions for detecting mutant anaplastic lymphoma kinase in human lung cancer	Patent 10955416 was granted and assigned to Cell Signaling Technology on March, 2021 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	10955416	March 23, 2021
‌ US Patent 9249231 Motif-specific and context-independent antibodies that specifically bind to a cleaved caspase motif	Patent 9249231 was granted and assigned to Cell Signaling Technology on February, 2016 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	9249231	February 2, 2016
‌ US Patent 9539254 Mutant ROS expression in human cancer	Patent 9539254 was granted and assigned to Cell Signaling Technology on January, 2017 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9539254	January 10, 2017
‌ US Patent 10000568 Compositions and methods for detecting EGFR in cancer	Patent 10000568 was granted and assigned to Cell Signaling Technology on June, 2018 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	10000568	June 19, 2018
‌ US Patent 9587013 Immunoaffinity isolation of modified peptides from complex mixtures	Patent 9587013 was granted and assigned to Cell Signaling Technology on March, 2017 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9587013	March 7, 2017
‌ US Patent 9856315 Methylation and acetylation sites	Patent 9856315 was granted and assigned to Cell Signaling Technology on January, 2018 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9856315	January 2, 2018
‌ US Patent 8466160 Identification of non-small cell lung carcinoma (NSCLC) tumors expressing PDGFR-alpha	Patent 8466160 was granted and assigned to Cell Signaling Technology on June, 2013 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	8466160	June 18, 2013
‌ US Patent 10036756 Mass spectrometry analysis of mutant polypeptides in biological samples	Patent 10036756 was granted and assigned to Cell Signaling Technology on July, 2018 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	10036756	July 31, 2018
‌ US Patent 9453845 Mass spectroscopy analysis of mutant polypeptides in biological samples	Patent 9453845 was granted and assigned to Cell Signaling Technology on September, 2016 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	9453845	September 27, 2016
‌ US Patent 9920110 Methods and reagents for creating monoclonal antibodies	Patent 9920110 was granted and assigned to Cell Signaling Technology on March, 2018 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	9920110	March 20, 2018
‌ US Patent 9738711 Production of motif-specific and context-independent antibodies using peptide libraries as antigens	Patent 9738711 was granted and assigned to Cell Signaling Technology on August, 2017 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9738711	August 22, 2017
‌ US Patent 10670606 Mass spectrometry analysis of mutant polypeptides in biological samples	Patent 10670606 was granted and assigned to Cell Signaling Technology on June, 2020 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	10670606	June 2, 2020
‌ US Patent 9102713 Analysis of ubiquitinated polypeptides	Patent 9102713 was granted and assigned to Cell Signaling Technology on August, 2015 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9102713	August 11, 2015
‌ US Patent 9328349 Translocation and mutant ROS kinase in human non-small cell lung carcinoma	Patent 9328349 was granted and assigned to Cell Signaling Technology on May, 2016 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9328349	May 3, 2016
‌ US Patent 9181326 Analysis of ubiquitinated polypeptides	Patent 9181326 was granted and assigned to Cell Signaling Technology on November, 2015 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9181326	November 10, 2015
‌ US Patent 9588110 Multi component antibody based detection technology	Patent 9588110 was granted and assigned to Cell Signaling Technology on March, 2017 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	9588110	March 7, 2017
‌ US Patent 9085609 Production of motif-specific and context-independent antibodies using peptide libraries as antigens	Patent 9085609 was granted and assigned to Cell Signaling Technology on July, 2015 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	9085609	July 21, 2015
‌ US Patent 9364477 Mutant ROS expression in human cancer	Patent 9364477 was granted and assigned to Cell Signaling Technology on June, 2016 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	9364477	June 14, 2016
‌ US Patent 9988688 Compositions for detecting mutant anaplastic lymphoma kinase in lung cancer	Patent 9988688 was granted and assigned to Cell Signaling Technology on June, 2018 by the United States Patent and Trademark Office.	Cell Signaling Technology	Cell Signaling Technology	United States Patent and Trademark Office	9988688	June 5, 2018
‌ US Patent 8481279 Methods of treating lung cancer using inhibitors anaplastic lymphoma kinase	Patent 8481279 was granted and assigned to Cell Signaling Technology on July, 2013 by the United States Patent and Trademark Office.		Cell Signaling Technology	United States Patent and Trademark Office	8481279	July 9, 2013

Results per page:

33 results

0 selected

33 results

0 selected